A carregar...

MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease

Inherited genetic modifiers and pharmacologic agents that enhance fetal hemoglobin (HbF) expression reverse the clinical severity of sickle cell disease (SCD). Recent efforts to develop novel strategies of HbF induction include discovery of molecular targets that regulate γ-globin gene transcription...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Hematol
Main Authors: Li, Biaoru, Zhu, Xingguo, Ward, Christina M., Starlard-Davenport, Athena, Takezaki, Mayuko, Berry, Amber, Ward, Alexander, Wilder, Caroline, Neunert, Cindy, Kutlar, Abdullah, Pace, Betty S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748328/
https://ncbi.nlm.nih.gov/pubmed/30412705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2018.11.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!